Market Tracker

10/22 7:58am ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

9.18
Data as of Oct 21
 +0.14 / +1.55%
Today’s Change
1.68
Today|||52-Week Range
9.83
+264.29%
Year-to-Date

Today’s Trading

Previous close9.04
Today’s open9.15
Day’s range-- - --
Volume395,890
Average volume (3 months)488,049
Market cap$343.9M
Dividend yield--
Data as of 10/21/2014

Growth & Valuation

Earnings growth (last year)-1,300.00%
Earnings growth (this year)+20.71%
Earnings growth (next 5 years)+3.90%
Revenue growth (last year)+38.43%
P/E ratioNM
Price/Sales1.08
Price/Book3.04

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...+0.06+0.76%
SUPNSupernus Pharmaceuti...+0.01+0.13%
PGNXProgenics Pharmaceut...-0.10-2.08%
DERMDermira Inc+0.32+2.21%
Data as of 10/21/2014

Financials

Next reporting dateNovember 18, 2014
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$84.9M
Annual profit (last year)-$25.6M
Net profit margin-30.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts